About

Jordan E. Angell is a leading figure in urologic oncology, with a research focus on advancing robotic surgical techniques for kidney cancer. His work centers on optimizing intraoperative tumor localization and improving outcomes for complex nephrectomy cases. Angell’s most influential contribution is his pioneering study on near-infrared fluorescence (NIRF) guidance during robotic partial nephrectomy, which demonstrated how indocyanine green dosing can differentiate tumors from healthy tissue. This 2013 paper, with 73 citations, has become a foundational reference for surgeons seeking to enhance precision and reduce positive margins. He further solidified his impact with a landmark 2015 study on robotic nephrectomy outcomes, the largest series at the time, which proved the safety and efficacy of robotic approaches even for the highest-complexity tumors (44 citations). By systematically addressing technical challenges—from dye optimization to case selection—Angell has helped expand the boundaries of minimally invasive kidney surgery. His work is essential reading for trainees and researchers aiming to master robotic oncology and improve patient outcomes through evidence-based surgical innovation.

Research Focus

Key Achievements

2
H-Index
2
Papers
117
Total Citations
59
Avg Citations/Paper
🏆 Most Cited Paper
Optimization of Near Infrared Fluorescence Tumor Localization during Robotic Partial Nephrectomy
73 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago